6th Annual Hematology and Medical Oncology Board Review: Contemporary Practice
In-Person Event
Mar 09 - 12, 2018
New York City, New York, USA
OVERVIEW
6th Annual Hematology and Medical Oncology Board Review: Contemporary Practice is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held during Mar 09 - 12, 2018 at Mortimer B. Zuckerman Research Center, New York, United States of America.
The target audience for this medical event is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents. This CME Conference has been approved for a maximum of 31.25 AMA PRA Category 1 Credits.
Conference Description :
This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.
Conference Objectives :
• State-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers
• State-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers
• Recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice
Additional details will be posted as soon as they are available.
The target audience for this medical event is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents. This CME Conference has been approved for a maximum of 31.25 AMA PRA Category 1 Credits.
Conference Description :
This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.
Conference Objectives :
• State-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers
• State-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers
• Recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice
Additional details will be posted as soon as they are available.
KEY DATES
09 Mar, 2018
Event Start Date
12 Mar, 2018
Event End Date
SPECIALITIES
OncologyHematology Blood and Marrow TransplantSUGGESTED HOTELS
CONFERENCE VENUE
Mortimer B. Zuckerman Research CenterRELATED CONFERENCES & LIVE WEBINARS
Quick Links